Article
Relationships of BRAF mutation and HMGB1 to papillary thyroid carcinoma.
Biochemical and biophysical research communications - 13 May 2017
Guan Xiaolei, Wang Ping, Chi Jingwei, Zhao Shihua, Wang Fei
Abstract excerpt
A poor papillary thyroid cancer (PTC) prognosis is strongly associated with the BRAF V600E mutation. During tumor progression, levels of the high mobility group box 1 (HMGB1) protein are often dysregulated. Results herein demonstrate that HMGB1 protein levels differ between tumor and adjacent non-tumor tissue and that HMGB1 mRNA levels were higher in wild-type BRAF PTC tissues than in BRAF V600E PTC tissues...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
